GSRx Introduces auraND™ Fixed Corridor Night+Day Progressives


Scottsdale, AZ, May 1, 2022 - GSRx, Inc. today announced availability of the auraND™ progressive lens. The premium fixed-corridor lens features ND4™ Pupil-Optimized Correction, a technology that delivers enhanced contrast and clearer vision at night and in low-light conditions. The auraND™ lens will be available at one price point for all materials (CR39, Trivex®, PolyTrue™, 1.60, TriBrid™, and 1.67).


The lens features the same technology as the epik™ Variable lens, but in a fixed-corridor design for specific patient needs. The technology provides for visual acuity over the entire lens, natural posture while reading, excellent 3D vision and spatial perception, spontaneous compatibility, sharp vision, and fatigue-free reading. It is available in fitting heights of 14, 17, and 20mm.


Pupil-Optimized Correction uses wavefront exam and patient data analyzed from over a million eyeglass wearers in a unique algorithm that optimizes the lens. ND4™ Night+Day technology does not require specialized equipment to prescribe. The result is enhanced contrast and clearer vision in all lighting conditions, for the best vision possible.

“We don’t add new technology to our portfolio unless we feel it is truly valuable to our partners and their patients,” commented David Jochims, GSRx CEO. “The benefits of our recently launched ND4 technology have been well-received, but we saw a need for it to also be available in a fixed-corridor progressive. auraND™ lenses add depth to the GSRx portfolio, giving our partners the best technology available to satisfy expectations and needs of their patients,” added Jochims


Additional product information is available at www.gsrx.com/aura.


***


GSRx levels the playing field for independent eye care with advanced customized lenses and premium coatings and treatments at a price point that allows practices to retain more patients in their optical, increase second pair sales and attract new patients. Learn more at www.gsrx.com.

128 views0 comments